These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22229256)

  • 41. Efficacy of combined therapy of goserelin and letrozole on very young women with advanced breast cancer as first-line endocrine therapy.
    Liu X; Qu H; Cao W; Wang Y; Ma Z; Li F; Wang H
    Endocr J; 2013; 60(6):819-28. PubMed ID: 23714650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].
    Long QQ; Zhang SF; Han Y; Chen H; Li XL; Hua KQ; Hu WG
    Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):247-51. PubMed ID: 20646533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial.
    Gong L; Zhang S; Han Y; Long Q; Zou S; Cao Y
    J Clin Pharmacol; 2015 Aug; 55(8):848-53. PubMed ID: 25694383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase II parallel group study showing comparable efficacy between premenopausal metastatic breast cancer patients treated with letrozole plus goserelin and postmenopausal patients treated with letrozole alone as first-line hormone therapy.
    Park IH; Ro J; Lee KS; Kim EA; Kwon Y; Nam BH; Jung SY; Lee S; Kim SW; Kang HS
    J Clin Oncol; 2010 Jun; 28(16):2705-11. PubMed ID: 20421538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.
    Suh KJ; Kim SH; Lee KH; Kim TY; Kim YJ; Han SW; Kang E; Kim EK; Kim K; No JH; Han W; Noh DY; Lee M; Kim HS; Im SA; Kim JH
    Cancer Res Treat; 2017 Oct; 49(4):1153-1163. PubMed ID: 28253566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
    Matsushima T; Akira S; Yoneyama K; Takeshita T
    Gynecol Endocrinol; 2020 Jun; 36(6):521-524. PubMed ID: 31661345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer.
    Zhang Z; Huang H; Feng F; Wang J; Cheng N
    J Gynecol Oncol; 2019 Jul; 30(4):e61. PubMed ID: 31074242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.
    Begum MR; Ferdous J; Begum A; Quadir E
    Fertil Steril; 2009 Sep; 92(3):853-857. PubMed ID: 18177867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical treatment for rectovaginal endometriosis: what is the evidence?
    Vercellini P; Crosignani PG; Somigliana E; Berlanda N; Barbara G; Fedele L
    Hum Reprod; 2009 Oct; 24(10):2504-14. PubMed ID: 19574277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis.
    Ferrero S; Camerini G; Seracchioli R; Ragni N; Venturini PL; Remorgida V
    Hum Reprod; 2009 Dec; 24(12):3033-41. PubMed ID: 19726448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
    Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.
    Loibl S; Turner NC; Ro J; Cristofanilli M; Iwata H; Im SA; Masuda N; Loi S; André F; Harbeck N; Verma S; Folkerd E; Puyana Theall K; Hoffman J; Zhang K; Bartlett CH; Dowsett M
    Oncologist; 2017 Sep; 22(9):1028-1038. PubMed ID: 28652278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of medical therapy in the management of uterine adenomyosis.
    Vannuccini S; Luisi S; Tosti C; Sorbi F; Petraglia F
    Fertil Steril; 2018 Mar; 109(3):398-405. PubMed ID: 29566852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure.
    Steiner N; Shrem G; Tannus S; Dahan SY; Balayla J; Volodarsky-Perel A; Tan SL; Dahan MH
    Fertil Steril; 2019 Jul; 112(1):98-104. PubMed ID: 31133384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman.
    Razzi S; Fava A; Sartini A; De Simone S; Cobellis L; Petraglia F
    BJOG; 2004 Feb; 111(2):182-4. PubMed ID: 14723761
    [No Abstract]   [Full Text] [Related]  

  • 58. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
    Ji M; Yuan M; Jiao X; Li Q; Huang Y; Li J; Wang G
    Gynecol Endocrinol; 2022 Feb; 38(2):164-169. PubMed ID: 34749585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study.
    Leone Roberti Maggiore U; Scala C; Venturini PL; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():157-62. PubMed ID: 25150954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up.
    Pierce SJ; Gazvani MR; Farquharson RG
    Fertil Steril; 2000 Nov; 74(5):964-8. PubMed ID: 11056241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.